Serebral Kreatin Eksikliği Sendromları ve Görüntüleme Bulguları

Botham KM, Mayes PA. (2018) The Respiratory Chain & Oxidative Phosphorylation. In: Rodwell VW, Bender DA, Botham KM, Kennelly PJ (eds). Harper's Illustrated Biochemistry. McGraw-Hill, New York.

Wyss M, Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol Rev. Jul 2000;80(3):1107-213. doi:10.1152/physrev.2000.80.3.1107

Brosnan JT, Brosnan ME. Creatine: endogenous metabolite, dietary, and therapeutic supplement. Annu Rev Nutr. 2007;27:241-61. doi:10.1146/annurev.nutr.27.061406.093621

Stockler-Ipsiroglu S, Apatean D, Battini R, et al. Arginine:glycine amidinotransferase (AGAT) deficiency: Clinical features and long term outcomes in 16 patients diagnosed worldwide. Mol Genet Metab. 2015;116(4):252-9. doi:10.1016/j.ymgme.2015.10.003

Uhlen M, Fagerberg L, Hallstrom BM, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347(6220):1260419. doi:10.1126/science.1260419

Fernandes-Pires G, Braissant O. Current and potential new treatment strategies for creatine deficiency syndromes. Mol Genet Metab. 2022;135(1):15-26. doi:10.1016/j.ymgme.2021.12.005

Braissant O, Beard E, Torrent C, Henry H. Dissociation of AGAT, GAMT and SLC6A8 in CNS: relevance to creatine deficiency syndromes. Neurobiol Dis. 2010;37(2):423-33. doi:10.1016/j.nbd.2009.10.022

Braissant O, Henry H. AGAT, GAMT and SLC6A8 distribution in the central nervous system, in relation to creatine deficiency syndromes: a review. J Inherit Metab Dis. 2008;31(2):230-9. doi:10.1007/s10545-008-0826-9

Braissant O, Henry H, Loup M, Eilers B, Bachmann C. Endogenous synthesis and transport of creatine in the rat brain: an in situ hybridization study. Brain Res Mol Brain Res. 31 2001;86(1-2):193-201. doi:10.1016/s0169-328x(00)00269-2

Li H, Thali RF, Smolak C, et al. Regulation of the creatine transporter by AMP-activated protein kinase in kidney epithelial cells. Am J Physiol Renal Physiol. 2010;299(1):F167-77. doi:10.1152/ajprenal.00162.2010

Mulik C, Mercimek-Andrews S. Creatine Deficiency Disorders: Phenotypes, Genotypes, Diagnosis, and Treatment Outcomes. Turk Arch Pediatr. 2023;58(2):129-35. doi:10.5152/TurkArchPediatr.2023.23022

Mercimek-Mahmutoglu S, Connolly MB, Poskitt KJ, et al. Treatment of intractable epilepsy in a female with SLC6A8 deficiency. Mol Genet Metab. 2010;101(4):409-12. doi:10.1016/j.ymgme.2010.08.016

van de Kamp JM, Mancini GM, Pouwels PJ, et al. Clinical features and X-inactivation in females heterozygous for creatine transporter defect. Clin Genet. 2011;79(3):264-72. doi:10.1111/j.1399-0004.2010.01460.x

Mercimek-Andrews S, Salomons GS. (2022) Creatine Deficiency Syndromes. In: Adam MP, Ardinger HH, Pagon RA, et al. (eds). GeneReviews. University of Washington, Seattle, Washington. https://www.ncbi.nlm.nih.gov/books/NBK3794/

Reichold M, Klootwijk ED, Reinders J, et al. Glycine Amidinotransferase (GATM), Renal Fanconi Syndrome, and Kidney Failure. J Am Soc Nephrol. 2018;29(7):1849-58. doi:10.1681/ASN.2017111179

Hanna-El-Daher L, Beard E, Henry H, Tenenbaum L, Braissant O. Mild guanidinoacetate increase under partial guanidinoacetate methyltransferase deficiency strongly affects brain cell development. Neurobiol Dis. 2015;79:14-27. doi:10.1016/j.nbd.2015.03.029

Stockler-Ipsiroglu S, van Karnebeek C, Longo N, et al. Guanidinoacetate methyltransferase (GAMT) deficiency: outcomes in 48 individuals and recommendations for diagnosis, treatment and monitoring. Mol Genet Metab. 2014;111(1):16-25. doi:10.1016/j.ymgme.2013.10.018

van de Kamp JM, Mancini GM, Salomons GS. X-linked creatine transporter deficiency: clinical aspects and pathophysiology. J Inherit Metab Dis. 2014;37(5):715-33. doi:10.1007/s10545-014-9713-8

Yildiz Y, Gocmen R, Yaramis A, Coskun T, Haliloglu G. Creatine Transporter Deficiency Presenting as Autism Spectrum Disorder. Pediatrics. Nov 2020;146(5)doi:10.1542/peds.2019-3460

Levin MD, Bianconi S, Smith A, et al. X-linked creatine transporter deficiency results in prolonged QTc and increased sudden death risk in humans and disease model. Genet Med. 2021;23(10):1864-72. doi:10.1038/s41436-021-01224-8

Mejdahl Nielsen M, Petersen ET, Fenger CD, et al. X-linked creatine transporter (SLC6A8) deficiency in females: Difficult to recognize, but a potentially treatable disease. Mol Genet Metab. 30 2023;140(3):107694. doi:10.1016/j.ymgme.2023.107694

Fons C, Campistol J. Creatine Defects and Central Nervous System. Semin Pediatr Neurol. 2016;23(4):285-9. doi:10.1016/j.spen.2016.11.003

Liserre R, Pinelli L, Gasparotti R. MR spectroscopy in pediatric neuroradiology. Transl Pediatr. 2021;10(4):1169-200. doi:10.21037/tp-20-445

Longo N, Ardon O, Vanzo R, Schwartz E, Pasquali M. Disorders of creatine transport and metabolism. Am J Med Genet C Semin Med Genet. 2011;157C(1):72-8. doi:10.1002/ajmg.c.30292

Sijens PE, Verbruggen KT, Meiners LC, Soorani-Lunsing RJ, Rake JP, Oudkerk M. 1H chemical shift imaging of the brain in guanidino methyltransferase deficiency, a creatine deficiency syndrome; guanidinoacetate accumulation in the gray matter. Eur Radiol. 2005;15(9):1923-6. doi:10.1007/s00330-005-2670-8

Sharer JD, Bodamer O, Longo N, Tortorelli S, Wamelink MM, Young S. Laboratory diagnosis of creatine deficiency syndromes: a technical standard and guideline of the American College of Medical Genetics and Genomics. Genet Med. 2017;19(2):256-63. doi:10.1038/gim.2016.203

Touati G, Mochel F, Artuch R. (2022) Diagnostic Procedures. In: Saudubray JM, Baumgartner MR, Garcia Cazorla A, Walter JH. (eds. Inborn Metabolic Diseases. Springer, Heidelberg.

Schulze A, Ebinger F, Rating D, Mayatepek E. Improving treatment of guanidinoacetate methyltransferase deficiency: reduction of guanidinoacetic acid in body fluids by arginine restriction and ornithine supplementation. Mol Genet Metab. 2001;74(4):413-9. doi:10.1006/mgme.2001.3257

Ream MA, Lam WKK, Grosse SD, et al. Evidence and Recommendation for Guanidinoacetate Methyltransferase Deficiency Newborn Screening. Pediatrics. 2023;152(2): e2023062100. doi:10.1542/peds.2023-062100

Bruun TUJ, Sidky S, Bandeira AO, et al. Treatment outcome of creatine transporter deficiency: international retrospective cohort study. Metab Brain Dis. 2018;33(3):875-884. doi:10.1007/s11011-018-0197-3

Dunbar M, Jaggumantri S, Sargent M, Stockler-Ipsiroglu S, van Karnebeek CD. Treatment of X-linked creatine transporter (SLC6A8) deficiency: systematic review of the literature and three new cases. Mol Genet Metab. 2014;112(4):259-74. doi:10.1016/j.ymgme.2014.05.011

Villar C, Campistol J, Fons C, et al. Glycine and L-arginine treatment causes hyperhomocysteinemia in cerebral creatine transporter deficiency patients. JIMD Rep. 2012;4:13-6. doi:10.1007/8904_2011_41

Ullio-Gamboa G, Udobi KC, Dezard S, et al. Dodecyl creatine ester-loaded nanoemulsion as a promising therapy for creatine transporter deficiency. Nanomedicine (Lond). 2019;14(12):1579-93. doi:10.2217/nnm-2019-0059

El-Kasaby A, Kasture A, Koban F, et al. Rescue by 4-phenylbutyrate of several misfolded creatine transporter-1 variants linked to the creatine transporter deficiency syndrome. Neuropharmacology. 2019;161:107572. doi:10.1016/j.neuropharm.2019.03.015